Table 2.
Type and number of each PROM questionnaire captured within this review, along with the associated trials which utilised each questionnaire.
| Questionnaire | Number of times used as instrument | Associated trials |
|---|---|---|
| EORTC QLQ-C30 (Quality of life of cancer patients) | 14 | 8,25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37 |
| EQ-5D (Generic quality of life) | 5 | 28,38, 39, 40, 41 |
| EPIC | 4 | 42, 43, 44, 45 |
| IPSS | 3 | 42,44,46 |
| AUA | 3 | 43,44,47 |
| M.D. Anderson Dysphagia Inventory | 2 | 8,28 |
| CLAS1 | 2 | 48,49 |
| CLAS2 | 2 | 48,49 |
| CLAS3 | 2 | 48,49 |
| FACT-G (General) | 2 | 50,51 |
| EORTC QLQ-H&N35 (Head & neck) | 2 | 8,28 |
| FACT-P (Prostate) | 1 | 39 |
| FACT-ES (Endocrine symptoms) | 1 | 52 |
| Impact of Pediatric Illness (IPI) Parent Report Form | 1 | 53 |
| Norfolk QOL-NET (Neuroendocrine tumour) | 1 | 54 |
| FACT-Ga (Gastric) | 1 | 55 |
| EORTC QLQ-LC13 (Lung) | 1 | 25 |
| VASB | 1 | 27 |
| WOMAC | 1 | 40 |
| PedsQL | 1 | 56 |
| SHIM | 1 | 46 |
| EORTC QLQ—STO22 (Gastric) | 1 | 55 |
| FACT-KSI (Kidney) | 1 | 50 |
| EORTC QLQ-BR23 (Breast) | 1 | 31 |
| DLIQ | 1 | 25 |
| Rectal function study questionnaire57 | 1 | 46 |
| VHI | 1 | 28 |
| EORTC QLQ-PAN26 (Pancreatic cancer) | 1 | 58 |
| O’Leary Interstitial Cystitis Symptom Index | 1 | 47 |
| EORTC QLQ-BN20 (Brain) | 1 | 34 |
| EORTC QLQ-PR25 (Prostate) | 1 | 35 |
| FAACT | 1 | 58 |
| FACT-BP (Bone pain) | 1 | 51 |
| MDASI-BT (Brain tumour) | 1 | 59 |
A table of acronyms used in this table are explained in Supplementary Table 3.